(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) and The University of Texas MD Anderson Cancer Center announced a multi-year strategic development collaboration to expand the evaluation of REZLIDHIA in ...
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) announced Tuesday that its collaboration partner, Kissei Pharmaceutical Co., Ltd., has released positive topline results from its Phase 3 clinical trial ...
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, clinical-stage drug development company Rigel Pharmaceuticals has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results